転移胃癌患者におけるイリノテカンとS-1併用療法の第1相試験

文献

J-GLOBAL ID：200902248084681990 整理番号：04A0019418

Phase I study of irinotecan and S-1 combination therapy in patients with metastatic gastric cancer

出版者サイト複写サービスで全文入手 {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=04A0019418&COPY=1") }}
高度な検索・分析はJDreamⅢで {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=04A0019418&from=J-GLOBAL&jstjournalNo=L3966A") }}

著者 (9件)： , , , , , , , ,
資料名：
巻： 8 号： 6 ページ： 374-380 発行年： 2003年12月
JST資料番号： L3966A ISSN： 1341-9625 資料種別：逐次刊行物 (A)
記事区分：原著論文発行国：ドイツ (DEU) 言語：英語 (EN)

イリノテカン(I)とS-1同時投与の最大耐量と推奨用量を決め...

,...
,...

続きはJDreamIII（有料）にて {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=04A0019418&from=J-GLOBAL&jstjournalNo=L3966A") }}

抗腫よう薬の臨床への応用 , 腫ようの薬物療法 , 消化器の腫よう

, , , , , ,

引用文献 (20件)：

OHTSU, A. Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer : The Japan Clinicla Oncology Group study (JCOG9205). J Clin Oncol. 2003, 21, 54-59
VANHOEFER, U. Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer : a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol. 2000, 18, 2648-2657
SHIRASAKA, T. Antitumor activity of 1 M tegafur-0.4M 5-chloro-2.4-dinydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats. Cancer Res. 1996, 56
TAGUCHI, T. Phase I study of S-1. Jpn J Cancer Chemother. 1997, 24, 2253-2264
SUGIMACHI, K. An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers. Oncology. 1999, 57, 202-210

, , , , ,

前のページに戻る